Company profile: Mytrus
1.1 - Company Overview
Company description
- Provider of clinical technology and services that enable people to safely participate in clinical trials from home, improving accessibility, convenience, and compliance while reducing costs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mytrus
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
GoBalto
HQ: United States
Website
- Description: Provider of cloud-based solutions for drug trial sponsors and clinical research organizations to simplify and accelerate clinical studies on the web. Offerings include tools for selecting, activating and analyzing clinical trial sites; a unified platform integrating people, processes and data; and safety case and signal management solutions supporting pharmacovigilance and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GoBalto company profile →
Suvoda
HQ: United States
Website
- Description: Provider of clinical trial management software and services, including Suvoda IRT to manage drug distribution and patient dosing, eConsent to enable electronic trial participation consent, and eCOA to collect patient outcome data, backed by client services and integration services to streamline trial processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suvoda company profile →
Datatrak
HQ: United States
Website
- Description: Provider of DATATRAK ONE® Unified Experience™, removing clinical research complexities and accelerating the ultimate outcome of every trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Datatrak company profile →
Devana Solutions
HQ: United States
Website
- Description: Provider of SaaS solutions that connect research sites with sponsors and CROs to reduce drug development costs through data transparency and selection of top-performing sites. PROPEL supports trial opportunity tracking and real-time collaboration; CENTRAL enables startup automation, pipeline and trial tracking, workflow automation, customizable dashboards; ENTERPRISE adds advanced collaboration, site capability queries, and comprehensive profiles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Devana Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mytrus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mytrus
2.2 - Growth funds investing in similar companies to Mytrus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mytrus
4.2 - Public trading comparable groups for Mytrus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →